We are live on ! Find out more
NMTC icon

NeuroOne Medical Technologies
NMTC

11 hedge funds and large institutions have $777K invested in NeuroOne Medical Technologies in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

1.28% less ownership

Funds ownership: 2% → 0.73% (-1.3%)

31% less funds holding

Funds holding: 16 → 11 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

79% less capital invested

Capital invested by funds: $3.77M → $777K (-$3M)

Holders
11
Holders Change
-5
Holders Change %
-31.25%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$75.2K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$70.2K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$44.8K
4
VF
Virtu Financial
New York
+$31.3K

Top Sellers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
-$921K
2
BL
Bleichroeder LP
New York
-$728K
3
SCM
Stonepine Capital Management
Oregon
-$505K
4
WVP
Worth Venture Partners
New Jersey
-$211K
5
EVC
Eidelman Virant Capital
Missouri
-$146K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$273K -$505K -41,708 -50%
Vanguard Group
2
Vanguard Group
Pennsylvania
$264K +$44.8K +3,694 +10%
DWM
3
Drive Wealth Management
Utah
$73K – – –
IC
4
Intersect Capital
California
$55K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$40K +$75.2K +6,208 New
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$38K +$70.2K +5,796 New
Northern Trust
7
Northern Trust
Illinois
$17K – – –
VF
8
Virtu Financial
New York
$17K +$31.3K +2,581 New
ACM
9
AIGH Capital Management
Maryland
– -$921K -79,167 Closed
BL
10
Bleichroeder LP
New York
– -$728K -62,500 Closed
WVP
11
Worth Venture Partners
New Jersey
– -$211K -18,161 Closed
EVC
12
Eidelman Virant Capital
Missouri
– -$146K -12,500 Closed
AC
13
Aristides Capital
Kentucky
– -$71K -6,133 Closed
Millennium Management
14
Millennium Management
New York
– -$29K -2,475 Closed
HF
15
HRT Financial
New York
– -$24K -2,147 Closed
TRCT
16
Tower Research Capital (TRC)
New York
– -$1K -48 Closed

NMTC Hedge Fund Activity: Q1 2022 in Review

11 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q1 2022, worth a combined $777K — down 79% from $3.77M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NMTC and 3 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $75.2K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $921K sold.

  • 11 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q1 2022, down from 16 in Q4 2021.
  • Funds reported $777K of NeuroOne Medical Technologies stock for Q1 2022, down 79% quarter-over-quarter.
  • 3 funds opened new NeuroOne Medical Technologies positions in Q1 2022 and 8 closed out, a net change of -5 holders.
  • The largest NeuroOne Medical Technologies buyer in Q1 2022 was Geode Capital Management, an estimated $75.2K added.
  • The largest NeuroOne Medical Technologies seller in Q1 2022 was AIGH Capital Management, an estimated $921K sold.

Based on aggregated 13F filings for Q1 2022.